Home / Clonazepam / Canada
CA ATC N03AE01 · updated 2 Nov 2026
Clonazepam shortage in Canada
Is there a Clonazepam shortage in Canada?
Yes. As of 2 Nov 2026, 7 Clonazepam products are reported short in Canada, the first since 11 Aug 2017. No return date has been given. Main reason: manufacturing problem.
Also short in United States, Belgium, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-CLONAZEPAM (100) | TEVA CANADA LIMITED | 11 Aug 2017 | not given | Active ingredient shortage Shortage of an active ingredient |
| CA | TEVA-CLONAZEPAM (500) | TEVA CANADA LIMITED | 11 Aug 2017 | not given | Active ingredient shortage Shortage of an active ingredient |
| CA | PRO-CLONAZEPAM (500) | PRO DOC LIMITEE | 4 Jul 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-CLONAZEPAM (500) | PRO DOC LIMITEE | 4 Jul 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-CLONAZEPAM (100 BTL) | APOTEX INC | 3 Mar 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-CLONAZEPAM (500 BTL) | APOTEX INC | 9 Jun 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-CLONAZEPAM (500) | PRO DOC LIMITEE | 4 Jul 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.